JPL Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
11,838
-567
-5% -$14.8K 0.06% 114
2026
Q1
$348K Buy
12,405
+1,632
+15% +$43.4K 0.08% 102
2025
Q4
$268K Sell
10,773
-677
-6% -$17.1K 0.07% 106
2025
Q3
$292K Buy
11,450
+196
+2% +$4.84K 0.07% 107
2025
Q2
$273K Buy
11,254
+15
+0.1% +$350 0.07% 103
2025
Q1
$285K Buy
11,239
+35
+0.3% +$916 0.08% 102
2024
Q4
$297K Buy
+11,204
New +$304K 0.09% 109
2024
Q1
Sell
-39,493
Closed -$1.14M 118
2023
Q4
$1.14M Buy
+39,493
New +$1.19M 0.82% 60

Other funds holding PFE

JPL Wealth Management's PFE Position: Q2 2026 in Review

JPL Wealth Management reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $14.8K and leaving 11,838 shares worth $285K. The position accounts for 0.06% of the portfolio, ranked #114.

JPL Wealth Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.14M in Q4 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • JPL Wealth Management held 11,838 shares of Pfizer worth $285K as of Q2 2026.
  • JPL Wealth Management sold 567 Pfizer shares in Q2 2026, an estimated $14.8K.
  • Pfizer made up 0.06% of JPL Wealth Management's portfolio in Q2 2026, its #114 holding.
  • JPL Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • JPL Wealth Management's Pfizer position peaked at $1.14M in Q4 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.